Prepare for the CPJE Law Test. Explore flashcards and multiple choice questions with detailed explanations. Ace your exam with comprehensive prep!

Multiple Choice

Regarding the 120-day supply limit for Schedule III/IV, which statement is true?

The key idea is that the 120-day supply limit for Schedule III/IV products applies to the quantity dispensed through refills within a 120-day window, not to the initial fill. The initial prescription fill is treated separately from that cap, so refills must stay within the 120-day limit, while the original fill isn’t counted toward that particular limit. This reflects the rule that regulators want to cap how much can be issued through repeats in a short period, without penalizing the patient’s initial therapeutic need. So, you can dispense the original fill as written, and then the refills must collectively stay within the 120-day limit for the 120-day window starting from that prescription, rather than counting the original fill toward that cap. The other statements would imply the initial fill counts toward the limit, or deny the limit exists, or abruptly reset across prescriptions, which isn’t accurate in this framework.

The key idea is that the 120-day supply limit for Schedule III/IV products applies to the quantity dispensed through refills within a 120-day window, not to the initial fill. The initial prescription fill is treated separately from that cap, so refills must stay within the 120-day limit, while the original fill isn’t counted toward that particular limit. This reflects the rule that regulators want to cap how much can be issued through repeats in a short period, without penalizing the patient’s initial therapeutic need.

So, you can dispense the original fill as written, and then the refills must collectively stay within the 120-day limit for the 120-day window starting from that prescription, rather than counting the original fill toward that cap. The other statements would imply the initial fill counts toward the limit, or deny the limit exists, or abruptly reset across prescriptions, which isn’t accurate in this framework.